SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-002260
Filing Date
2023-02-01
Accepted
2023-02-01 16:34:01
Documents
14
Period of Report
2023-01-26
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbli20230131_8k.htm   iXBRL 8-K 46749
2 EXHIBIT 3.2 ex_469928.htm EX-3.2 5542
  Complete submission text file 0001437749-23-002260.txt   189925

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA stab-20230126.xsd EX-101.SCH 3600
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stab-20230126_def.xml EX-101.DEF 11543
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE stab-20230126_lab.xml EX-101.LAB 15439
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stab-20230126_pre.xml EX-101.PRE 11699
8 EXTRACTED XBRL INSTANCE DOCUMENT cbli20230131_8k_htm.xml XML 2579
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 23577283
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences